Alex AM, Levendosky AA, Bogat GA, et al. Stress and mental health symptoms in early pregnancy are associated with the oral microbiome. BMJ Ment Health 2024;27:e301100.
Alon N, Macrynikola N, Jester D et al. Social determinants of mental health in major depressive disorder: Umbrella review of 26 meta-analyses and systematic reviews. Psychiatry Research 2024, 335 115854. https://doi.org/10.1016/j.psychres.2024.115854
Biernacka N, Talwar S, Billings J. Trauma clinicians’ views of physical exercise as part of PTSD and complex PTSD treatment: A qualitative study. PLOS Mental Health 2024, 1(4), e0000114.
Brand BA, Sommer IE, Gangadin SS et al. Real-world effectiveness of menopausal hormone therapy in preventing relapse in women with schizophrenia or schizoaffective disorder. American Journal of Psychiatry, 181(10), 893-900. DOI: 10.1176/appi.ajp.20230850
Cooper RE, Saunders KRK, Greenburgh A et al. The effectiveness, implementation, and experiences of peer support approaches for mental health: A systematic umbrella review. BMC Medicine 2024, 22(1), 72. https://doi.org/10.1186/s12916-024-03260-y
Garcia-Argibay M, Chang Z, Brikell I. et al. Evaluating ADHD medication trial representativeness: a Swedish population-based study comparing hypothetically trial-eligible and trial-ineligible individuals. The Lancet Psychiatry 2025, Volume 12, Issue 2, 131 - 139.
Gilbert E, Villa D, Riley GA. A scoping review of psychosocial interventions to enhance the relationship of couples living with dementia. Dementia 2023, 22(5), 1164–1198.
Griffiths JL, Saunders KRK, Foye U et al. The use and impact of surveillance-based technology initiatives in inpatient and acute mental health settings: a systematic review. BMC Med 22, 564 (2024). https://doi.org/10.1186/s12916-024-03673-9
Henssler J, Schmidt Y, Schmidt U, et al. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. The Lancet Psychiatry 2024, 11(7), 526–535.
Ishrat S, Levey DF, Gelernter J, et al. Association between cannabis use and brain structure and function: an observational and Mendelian randomisation study. BMJ Ment Health 2024;27:e301065.
Lee M, Cernvall M, Borg J, et al. Cognitive Function and Variability in Antipsychotic Drug–Naive Patients With First-Episode Psychosis: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2024 May 1;81(5):530. doi: 10.1001/jamapsychiatry.2024.0779.
Linardon J, Torous J, Firth J, et al. Current evidence on the efficacy of mental health smartphone apps for symptoms of depression and anxiety. A meta‐analysis of 176 randomized controlled trials. World Psychiatry 2024, 23(1), 139-149.
NICE. 2025. Digitally enabled therapies for adults with depression: early value assessment.
Health technology evaluation [HTE8]. Published: 16 May 2023. Last updated: 14 January 2025.
NICE. 2024. Digital technologies for assessing attention deficit hyperactivity disorder (ADHD). Diagnostics guidance. Reference number: DG60. Published: 21 October 2024.
Oquendo MA, Wall M, Wang S, Olfson M, Blanco C. Lifetime Suicide Attempts in Otherwise Psychiatrically Healthy Individuals. JAMA Psychiatry. 2024;81(6):572–578. doi:10.1001/jamapsychiatry.2023.5672
Salahuddin NH, Schütz A, Pitschel-Walz G, et al. Psychological and psychosocial interventions for treatment-resistant schizophrenia: a systematic review and network meta-analysis. The Lancet Psychiatry 2024, 11(7), 545-553. https://doi.org/10.1016/S2215-0366(24)00136-6
Thomas PC, Curtis K, Potts HW et al. Behavior Change Techniques Within Digital Interventions for the Treatment of Eating Disorders: Systematic Review and Meta-Analysis. JMIR Mental Health 2024, 11, e57577.
Winter-van Rossum I, Slot M, van Hell H et al. Effectiveness of Omega-3 Fatty Acids Versus Placebo in Subjects at Ultra-High Risk for Psychosis: The PURPOSE Randomized Clinical Trial. Schizophr Bull. 2024 Oct 25:sbae186. https://doi.org/10.1093/schbul/sbae186
